Celltrion Will Market Subcutaneous Remsima Directly After EU Nod

 
• By David Wallace and Jung Won Shin
  
EMA
The EMA’s CHMP has endorsed Celltrion’s subcutaneous infliximab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business